title: [Primary antiphospholipid syndrome].
abstract: Antiphospholipid syndrome (APS) is a disorder characterised by recurrent arterial or venous thrombosis and/or pregnancy losses, in the presence of persistently elevated levels of anticardiolipin antibodies and/or evidence of circulating lupus anticoagulant (these abnormalities are detected by blood tests). Primary APS occurs when there is no evidence of associated diseases. APS in the presence of an underlying disease, usually systemic lupus erythematosus, is called secondary APS.
authors: Spitalul Universitar De Urgenta Bucuresti, Clinica Oftalmologie.
authors: Angela
authors: A
authors: Popa
authors: Liliana
authors: L
authors: Voinea
authors: Monica
authors: M
authors: Pop
authors: Daniela
authors: D
authors: Stana
authors: Ana-Maria
authors: AM
authors: Dascalu
authors: Cristina
authors: C
authors: Alexandrescu
authors: R
authors: R
authors: Ciuluvica
mesh_terms: D017153:Antibodies, Anticardiolipin / Q000097:blood*; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D005451:Fluorescein Angiography; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D011379:Prognosis; D013927:Thrombosis / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D015415:Biomarkers; D016682:Lupus Coagulation Inhibitor